Cargando…
Bolus or continuous hydrocortisone – that is the question
Constantly evolving treatment guidelines based on a growing body of randomized controlled trials are helping us to improve outcomes in sepsis. However, it must be borne in mind that proven benefit from individual sepsis treatments does not guarantee synergistic beneficial effects when new treatments...
Autores principales: | Weber-Carstens, Steffen, Keh, Didier |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2151867/ https://www.ncbi.nlm.nih.gov/pubmed/17316466 http://dx.doi.org/10.1186/cc5669 |
Ejemplares similares
-
Impact of continuous versus bolus low-dose hydrocortisone application on blood glucose in septic shock patients
por: Weber-Carstens, S, et al.
Publicado: (2005) -
Hyperglycemia Risk Evaluation of Hydrocortisone Intermittent Boluses vs Continuous Infusion in Septic Shock: A Retrospective Study
por: Mitwally, Hassan, et al.
Publicado: (2021) -
Hyperglycemia Risk Evaluation of Hydrocortisone Intermittent Boluses versus Continuous Infusion in Septic Shock: A Prospective Randomized Trial
por: Ram, Ganesh Kumar, et al.
Publicado: (2022) -
Milrinone: Is Bolus Bad?
por: Kulkarni, Venugopal
Publicado: (2018) -
Effects of hydrocortisone stress-dose therapy in septic shock (part I): influence on hemodynamic stability and plasma nitrite/nitrate levels
por: Keh, D, et al.
Publicado: (1999)